Giuliano R.
- Country
- Italy
- Department
- I Division Infectious disease
Research Overview
- A Phase 3 Open-label Clinical Study of Doravirine/Islatravir (DOR/ISL [100 mg/0.25 mg]) Once Daily for the Treatment of HIV-1 Infection in Participants Who Previously Received DOR/ISL (100 mg/0.75 mg) QD in a Phase 3 Clinical Study
- A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate a Switch to Doravirine/Islatravir (DOR/ISL 100 mg/0.25 mg) Once-Daily in Participants With HIV-1 Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF)
- Phase 3 Randomized Double‑Blind Study of Doravirine/Islatravir Versus Bictegravir Combination Therapy in Treatment‑Naïve HIV‑1 Infection
Data & Insights
Has run more than one trial at 42 of 61 partner sites.
Specializations
HIV Treatment Innovation
The investigator specializes in antiretroviral therapy optimization, with particular focus on evaluating novel treatment combinations for HIV-1 infected patients.
- Two-drug therapy evaluation
- Treatment switching strategies
- Virological efficacy assessment
Key interests include investigating dual-therapy regimens and their potential to replace traditional three-drug combinations.
Women's Health in HIV
Demonstrates specific expertise in studying HIV treatment approaches for women, particularly focusing on treatment optimization for virologically suppressed female patients.
- Gender-specific treatment responses
- Treatment simplification strategies
- Long-term efficacy monitoring
Specializes in evaluating treatment outcomes in adult women receiving various antiretroviral combinations.
Novel Therapeutic Approaches
Focuses on investigating innovative antiretroviral combinations, including studies of doravirine/islatravir and other emerging treatment options.
- Treatment-naïve patient therapy
- Safety and tolerability assessment
- Long-term therapeutic outcomes
Evaluates both established and experimental treatment regimens for managing HIV-1 infection.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.